By Marisa Wong and Cristal Cody
Los Angeles, March 2 – Roche Holdings, Inc. priced $1.5 billion of notes due March 5, 2024 in three tranches on Monday, according to a market source.
Roche priced $350 million of floating-rate notes at SOFR plus 24 basis points.
The company priced $500 million of 0.45% notes at Treasuries plus 20 basis points. Price talk was in the Treasuries plus 35 bps to 40 bps area.
The third tranche consists of $650 million of 0.691% notes priced at Treasuries plus 30 bps. Talk was in the Treasuries plus 45 bps to 50 bps area.
BNP Paribas Securities Corp., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and MUFG are the bookrunners.
Roche is a Basel, Switzerland-based drug maker.
Issuer: | Roche Holdings, Inc.
|
Issue: | Notes
|
Amount: | $1.5 billion
|
Maturity: | March 5, 2024
|
Bookrunners: | BNP Paribas Securities Corp., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC and MUFG
|
Pricing date: | March 1
|
|
Floating-rate notes
|
Amount: | $350 million
|
Coupon: | SOFR plus 24 bps
|
|
0.45% notes
|
Amount: | $500 million
|
Coupon: | 0.45%
|
Spread: | 20 bps over Treasuries
|
Talk: | 35 bps to 40 bps area over Treasuries
|
|
0.691% notes
|
Amount: | $650 million
|
Coupon: | 0.691%
|
Spread: | 30 bps over Treasuries
|
Talk: | 45 bps to 50 bps area over Treasuries
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.